NRC Health (NRC)

NRC Health is a NASDAQ-listed common stock issuer focused on healthcare analytics and experience management in the United States. The company develops tools and subscription-based solutions that help healthcare organizations measure and improve patient, employee, and consumer experiences. Its offerings include market experience services for brand awareness, perception, differentiation, and community segmentation; patient experience platforms for tracking engagement and loyalty across care settings; and employee experience solutions covering engagement, culture, safety, and nurse satisfaction. NRC Health also provides consumer experience products such as online reputation management and community insights, along with Huey, an AI engine designed for healthcare experience management. In addition, the company supports governance through conferences, publications, advisory services, and an online portal for health system boards, executives, and physician leaders. Founded in 1981 and headquartered in Lincoln, Nebraska, the company was formerly known as National Research Corporation and adopted the NRC Health name in April 2026.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-NRC
$18.45
-15.6% Downside
Fair
$26
18.9% Upside
Undervalued
Fair
September 25, 2026
October 9, 2026
3.0%
November 3, 2026
88.2x
73.8x
3.5x
483.5 M
570.7 M
16.1%
53.4%
4.4
216.9%
394.7%
Valuation • Fair Value

NRC Health (NASDAQ-NRC) Fair Value by Valuation Model

Review the available estimates for NRC Health (NASDAQ-NRC), including DCF Fair Value, Ben Graham Formula Value, DDM Fair Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$18.45

Estimated downside of 15.6% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$21.04

Discounted cash flow valuation reference.

Ben Graham Formula Value

$2.75

Classic Ben Graham valuation formula reference.

DDM Fair Value

$12.08

Dividend discount model valuation reference.

EPV Fair Value

$12.62

Earnings power value estimate.

Comps Fair Value

$18.96

Comparable-company valuation reference.

Analyst Price Target

$26

Analysts imply upside of 18.9%.

How to read these valuation models

Use the 8 available valuation references for NRC Health (NASDAQ-NRC) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for NRC Health (NASDAQ-NRC)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

140 M

Current operating scale indicator.

Revenue Forecast

142.6 M

Forward revenue estimate.

EBITDA

26.675 M

Current operating profitability reference.

EBITDA Forecast

39.1 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review NRC Health (NASDAQ-NRC) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for NRC Health (NASDAQ-NRC)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-3.66

No elevated caution signal from this screen.

Altman Z-Score

4.4

Relatively strong balance-sheet zone.

FCF / Net Income

394.7%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for NRC Health (NASDAQ-NRC). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for NRC Health (NASDAQ-NRC)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 3, 2026

Days to Earnings

42

Dividend Payment Date

October 9, 2026

Ex-Dividend Date

September 25, 2026

Dividend Yield

3.0%

Current income yield reference.

Payout Ratio

216.9%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for NRC Health (NASDAQ-NRC), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for NRC Health (NASDAQ-NRC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for NRC Health (NASDAQ-NRC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for NRC Health (NASDAQ-NRC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for NRC Health (NASDAQ-NRC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for NRC Health (NASDAQ-NRC) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

NRC Health (NASDAQ-NRC) Stock FAQ

Data-supported answers about NRC Health (NASDAQ-NRC), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$18.45
Estimated downside 15.6%
Valuation Rating
Overvalued
Estimated downside of 15.6%
Analyst Target
$26
Implied upside 18.9%
Financial Health
Fair
Current financial-health read

The current fair value estimate for NRC Health (NASDAQ-NRC) is $18.45. This implies an estimated downside of 15.6% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 15.6% versus the current market price.

The available analyst price target for NRC Health (NASDAQ-NRC) is $26. The analyst target implies estimated upside of 18.9%.

The current financial health read for NRC Health (NASDAQ-NRC) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for NRC Health (NASDAQ-NRC) is November 3, 2026.

Based on the current data, dividend yield is 3.0%, ex-dividend date is September 25, 2026, payment date is October 9, 2026.

The current P/E ratio listed for NRC Health (NASDAQ-NRC) is 88.2x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for NRC Health is 483.5 M.

The current enterprise value listed for NRC Health is 570.7 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for NRC Health is NASDAQ-NRC, and the stock is listed on NASDAQ.

NRC Health (NASDAQ-NRC) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for NRC Health is 16.1%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for NRC Health is 53.4%. Free float helps investors understand how much of the share base is available for public trading.